Jump Financial’s Ocular Therapeutix OCUL Stock Holding History

Jump Financial’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.45M	Sell	350,937 -50,896	-13%	-$461K	0.03%	660
2026 Q1	$3.4M	Buy	401,833 +228,040	+131%	+$2.17M	0.05%	459
2025 Q4	$2.11M	Buy	173,793 +111,569	+179%	+$1.36M	0.03%	653
2025 Q3	$727K	Buy	+62,224	New	+$744K	0.01%	1150
2024 Q3	–	Sell	-123,442	Closed	-$844K	–	1982
2024 Q2	$844K	Buy	123,442 +80,123	+185%	+$495K	0.02%	898
2024 Q1	$394K	Buy	+43,319	New	+$307K	0.01%	1305
2023 Q3	–	Sell	-220,300	Closed	-$1.14M	–	2136
2023 Q2	$1.14M	Buy	220,300 +108,300	+97%	+$644K	0.04%	615
2023 Q1	$590K	Buy	+112,000	New	+$532K	0.02%	817
2021 Q4	–	Sell	-60,300	Closed	-$603K	–	1617
2021 Q3	$603K	Sell	60,300 -17,011	-22%	-$191K	0.04%	430
2021 Q2	$1.1M	Buy	+77,311	New	+$1.18M	0.11%	254
2020 Q4	–	Sell	-16,200	Closed	-$123K	–	1113
2020 Q3	$123K	Buy	+16,200	New	+$134K	0.02%	682

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Financial's OCUL Position: Q2 2026 in Review

Jump Financial reduced its Ocular Therapeutix (OCUL) stake by 13% in Q2 2026, selling an estimated $461K and leaving 350,937 shares worth $3.45M. The position accounts for 0.03% of the portfolio, ranked #660.

Jump Financial first reported a position in OCUL in Q3 2020 and has held it in 11 quarters since. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

Jump Financial held 350,937 shares of Ocular Therapeutix worth $3.45M as of Q2 2026.
Jump Financial sold 50,896 Ocular Therapeutix shares in Q2 2026, an estimated $461K.
Ocular Therapeutix made up 0.03% of Jump Financial's portfolio in Q2 2026, its #660 holding.
Jump Financial first reported a position in Ocular Therapeutix in Q3 2020 and has held it in 11 quarters since.
262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.